These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1498895)

  • 1. Pharmacological replacement of cholinergic function in Alzheimer disease.
    Giacobini E
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():412A-413A. PubMed ID: 1498895
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
    Winblad B; Messamore E; O'Neill C; Cowburn R
    Acta Neurol Scand Suppl; 1993; 149():4-6. PubMed ID: 8128837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic cholinergic agonists: pharmacological and clinical perspectives.
    Palacios JM; Spiegel R
    Prog Brain Res; 1986; 70():485-98. PubMed ID: 3554361
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinergic strategies in the treatment of Alzheimer's disease.
    Davidson M; Stern RG; Bierer LM; Horvath TB; Zemishlani Z; Markofsky R; Mohs RC
    Acta Psychiatr Scand Suppl; 1991; 366():47-51. PubMed ID: 1897375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of cholinergic preparations in Alzheimer's disease].
    Bradley RJ; Edge MT; Freeman AM
    Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Alzheimer's disease with cholinergic drugs.
    Kumar V; Calache M
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can drugs improve memory?
    Kent S
    Geriatrics; 1979 Jul; 34(7):77, 80, 83 passim. PubMed ID: 376407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A; Rüster P; Romero B; Zimmer R
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M; Stern RG
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological correction of Alzheimer's disease (review of the literature)].
    Groppa SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):110-6. PubMed ID: 1686127
    [No Abstract]   [Full Text] [Related]  

  • 11. The cholinergic system and EEG slow waves.
    Riekkinen P; Buzsaki G; Riekkinen P; Soininen H; Partanen J
    Electroencephalogr Clin Neurophysiol; 1991 Feb; 78(2):89-96. PubMed ID: 1704840
    [No Abstract]   [Full Text] [Related]  

  • 12. New insights into genetics and pathophysiology of Alzheimer's disease: what are the clinical and therapeutic implications?
    J Clin Psychiatry; 2000 Apr; 61(4):307-15. PubMed ID: 10830158
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.
    Kaufer D
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():8-14. PubMed ID: 9718229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 16. Present state and future development of the therapy of Alzheimer disease.
    Pomponi M; Giacobini E; Brufani M
    Aging (Milano); 1990 Jun; 2(2):125-53. PubMed ID: 2095855
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacotherapy of Alzheimer disease: new drugs and novel strategies.
    Giacobini E
    Prog Brain Res; 1993; 98():447-54. PubMed ID: 8248535
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs and the parasympathetic nervous system.
    Smith SE
    Nurs Times; 1972 Mar; 68(9):256-7. PubMed ID: 5018119
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic progress--review XVIII Alzheimer's disease.
    Kendall MJ; Chellingsworth MC; Main AN
    J Clin Hosp Pharm; 1985 Dec; 10(4):327-36. PubMed ID: 2869054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.